Earlier quoted context omitted.
>Less than two years from lab to clinic is highly unusual. I assume like most other COVID vaccines/treatments, the timeline is shrunk by going straight to more expensive phases of the trial instead of having preliminary ones of escalating cost and confidence. Or at least prepping for them. For instance, all the vaccines started setting up commercial production around the same time they started trials, because it's no…
This has interesting implications when we consider how much money drug companies “should” be paid for inventing important new life-saving medicines. I frequently hear/read complaints of "that's outrageous [that this medicine costs $X]!" Well, maybe it is; maybe it isn't, but if you make sure it costs $X/100, I can be pretty sure you'll get less drug R&D.
It's interesting to note that the Pfizer, AstroZeneca and J&J vaccines were all invented by 3rd parties.